$TOMZ earnings report

TOMI reports Q3 2026 sales up 24% to $2,492,801 and first positive operating income since Q3 2024; net results remain subject to convertible notes accounting review. AlphAI read TOMI Environmental Solutions's Q3 FY2026 filing as mixed.

Q3 FY2026

AlphAI · Earnings readTOMZ · Q3 2026 · ended 2026-09-30

TOMI reports Q3 2026 sales up 24% to $2,492,801 and first positive operating income since Q3 2024; net results remain subject to convertible notes accounting review

→Mixed quarter

Revenue growth, gross profit growth, lower operating expenses and positive operating income are reported. Results are preliminary and unaudited, the company states that a convertible notes accounting review is not complete and that net loss and net loss per share are not included in the release, and the printed statements carry net loss figures that the release text says are excluded.

Revenue
approximately $2,078,000
30% y/y
Product revenue
approximately $2,078,000 (Q3 2026)
30% y/y
Gross margin · GAAP
59.0%

Key metrics

as reported
MetricValueq/qy/y
Sales, net, Q3 2026 (three months ended September 30, 2026)GAAP$2,492,80111%24%
Sales, net, nine months 2026 (nine months ended September 30, 2026)GAAP$6,393,937–38%
Product revenue, Q3 2026otherapproximately $2,078,000–30%
Service revenue, Q3 2026otherapproximately $415,000–1%
Cost of sales, Q3 2026GAAP$1,022,880––
Cost of sales, nine months 2026GAAP$2,706,934––
Gross profit, Q3 2026GAAP$1,469,921–19%
Gross profit, nine months 2026GAAP$3,687,003–29%
Gross margin, Q3 2026GAAP59.0%––
Professional fees, Q3 2026GAAP$276,021––
Professional fees, nine months 2026GAAP$800,684––
Depreciation and amortization, Q3 2026GAAP$47,872––
Depreciation and amortization, nine months 2026GAAP$150,821––
Selling expenses, Q3 2026GAAP$197,049––
Selling expenses, nine months 2026GAAP$617,377––
Research and development, Q3 2026GAAP$42,504––
Research and development, nine months 2026GAAP$137,376––
Consulting fees, Q3 2026GAAP$94,692––
Consulting fees, nine months 2026GAAP$341,487––
General and administrative, Q3 2026GAAP$781,736––
General and administrative, nine months 2026GAAP$2,479,619––
Total operating expenses, Q3 2026GAAP$1,439,874decreased 12%decreased 7%
Total operating expenses, nine months 2026GAAP$4,527,364–declined 11%
Income (loss) from operations, Q3 2026GAAP$30,047–improvement of $351,462
Income (loss) from operations, nine months 2026GAAP$(840,361)–operating loss improved approximately 62%
Other income (Employee Retention Credit), nine months 2026GAAP-––
Interest income, Q3 2026GAAP$2,133––
Interest income, nine months 2026GAAP$2,649––
Interest expense, Q3 2026GAAP$(74,412)––
Interest expense, nine months 2026GAAP$(397,465)––
Loss on extinguishment of convertible debt, Q3 2026GAAP$(146,754)––
Loss on extinguishment of convertible debt, nine months 2026GAAP$(146,754)––
Total other income (expense), Q3 2026GAAP$(219,033)––
Total other income (expense), nine months 2026GAAP$(541,570)––
Loss before income taxes, Q3 2026GAAP$(188,986)––
Loss before income taxes, nine months 2026GAAP$(1,381,931)––
Provision for income taxes, Q3 2026GAAP-––
Net loss, Q3 2026 (as printed in the statement of operations)GAAP($188,986)––
Net loss, nine months 2026 (as printed in the statement of operations)GAAP($1,381,931)––
Net loss per common share, basic, Q3 2026GAAP($0.02)––
Net loss per common share, diluted, Q3 2026GAAP($0.02)––
Net loss per common share, basic, nine months 2026GAAP($0.18)––
Net loss per common share, diluted, nine months 2026GAAP($0.18)––

Segments

SegmentRevenueq/qy/y
Product revenueThe filing reports the increase and attributes the quarter's commercial results to stronger commercial execution and improved equipment sales, per the CEO. No product-specific driver is stated.approximately $2,078,000 (Q3 2026)–30%
Service revenueNo driver stated in the filing.approximately $415,000 (Q3 2026)–1%
U.S. revenueNo driver stated in the filing.approximately $1,921,000 (Q3 2026)–50%
International revenueNo driver stated in the filing.approximately $572,000 (Q3 2026)–decreased 22%

Shareholders' equity at September 30, 2026 outlook

  • NoteThe company expects shareholders' equity at September 30, 2026 to be in the range of $3 Million to $4 Million.

Capital returns

  • No share repurchases or cash dividends are reported in the filing.
  • 1-for-3 reverse stock split of Common Stock and Series A Preferred Stock effected on July 20, 2026.
  • The company states that $2.5 million of convertible notes were converted during the third quarter.
  • Loss on extinguishment of convertible debt of $(146,754) is reported for Q3 2026 and nine months 2026; the release states the review of the accounting for the conversion is not complete.

What drove it

  • Company states that the quarter reflects stronger commercial execution, improved equipment sales and disciplined management of the operating cost base.
  • Company states operating expenses decreased 7% year-over-year and 12% sequentially, reflecting continued expense discipline.
  • Company states that, based on 2026 invoiced sales and open orders compared with full-year 2025 levels, iHP Support Services increased approximately 133%, Mobile Equipment increased approximately 106%, and CES/Enclosure sales increased approximately 259%; BIT Solution sales are stated to be on track to exceed 2025.
  • Sales backlog was approximately $2.5 million at September 30, 2026 and approximately $2.8 million subsequently; total sales pipeline approximately $35 million, with approximately 25% in advanced stages.
  • Company states that the convertible note conversion significantly reduced debt obligations and expected annual cash interest commitment, per the CEO.

Concerns

  • The release states results are preliminary and unaudited, and that the company and its auditor have not completed their review of the accounting for the convertible notes, including the $2.5 million of notes converted in Q3.
  • The release text states that net loss, net loss per share and related liability and equity balances are not included, while the statement of operations and balance sheet print net loss of ($188,986) for Q3 2026 and total shareholders' equity of $4,012,524. The company states it does not expect the review to affect revenue, gross profit, operating expenses or income from operations.
  • The release expects shareholders' equity at September 30, 2026 to be in the range of $3 Million to $4 Million; the printed unaudited balance sheet shows $4,012,524, which is above that range.
  • Gross margin declined to 59.0% from 61.2% in the prior-year quarter.
  • International revenue decreased 22% to approximately $572,000.
  • Net loss of ($1,381,931) for nine months 2026 remains large relative to sales of $6,393,937, and interest expense for nine months 2026 is $(397,465).
  • Accounts receivable rose to $2,592,871 from $689,153 at December 31, 2025, and accounts payable rose to $2,583,459 from $1,480,189.

What to watch

  • Final 10-Q for the period ended September 30, 2026, including the accounting for the convertible note conversion, the gain or loss on conversion, net loss and net loss per share.
  • Whether shareholders' equity at September 30, 2026 falls within the $3 Million to $4 Million range stated in the release once final.
  • Conversion of the approximately $2.8 million post-quarter backlog and the approximately $35 million pipeline into revenue.
  • Sustainability of operating income, which is stated as approximately $30,000 for Q3 2026 against an operating loss of ($244,142) in Q2 2026.
  • Gross margin trend against 59.0% in Q3 2026 and 61.2% in Q3 2025.
  • International revenue after the 22% decrease, and the India pharmaceutical opportunity described as post-quarter.
  • Cash position of $195,162 and the operating cash flow, which the filing does not provide.

Balance sheet and cash flow

  • Cash and cash equivalents: $195,162 at September 30, 2026 vs $87,775 at December 31, 2025.
  • Accounts receivable, net: $2,592,871 at September 30, 2026 vs $689,153 at December 31, 2025.
  • Inventories, net: $2,381,336 at September 30, 2026 vs $2,926,427 at December 31, 2025.
  • Total current assets: $5,920,597 at September 30, 2026 vs $4,187,066 at December 31, 2025.
  • Total assets: $8,830,024 at September 30, 2026 vs $7,034,301 at December 31, 2025.
  • Accounts payable: $2,583,459 at September 30, 2026 vs $1,480,189 at December 31, 2025.
  • Deferred revenue: $171,345 at September 30, 2026 vs $424,032 at December 31, 2025.
  • Sale of future receipts, net: none at September 30, 2026 vs $254,234 at December 31, 2025.
  • Convertible notes payable, net of unamortized discount: $592,475 at September 30, 2026 vs $2,912,376 at December 31, 2025; unamortized discount of $42,525 and $222,624 respectively.
  • Total liabilities: $4,817,501 at September 30, 2026 vs $6,445,797 at December 31, 2025.
  • Total shareholders' equity: $4,012,524 at September 30, 2026 vs $588,504 at December 31, 2025.
  • Operating cash flow, free cash flow and cash flow statement: not provided in the filing.

Analysis

TOMI reported preliminary, unaudited results for the third quarter of 2026. Sales, net rose 24% year-over-year to $2,492,801 and 11% sequentially from $2,246,909 in Q2 2026. For the nine months, sales were $6,393,937, up 38% from $4,619,229. The company attributes the growth to stronger commercial execution and improved equipment sales. Within revenue, product revenue was approximately $2,078,000, up 30%, and service revenue was approximately $415,000, up 1%. U.S. revenue rose 50% to approximately $1,921,000, while international revenue fell 22% to approximately $572,000. The company's stated order data, measured against full-year 2025 levels, shows large percentage increases in iHP Support Services, Mobile Equipment and CES/Enclosure sales.

Profitability moved in the same direction as sales. Gross profit increased 19% to $1,469,921, but gross margin fell to 59.0% from 61.2% in Q3 2025, so gross profit grew more slowly than sales. Total operating expenses decreased 7% year-over-year to $1,439,874 and 12% sequentially, with general and administrative expense down to $781,736 from $1,072,406 while professional fees rose to $276,021 from $185,476. The result was income from operations of $30,047, compared with an operating loss of ($321,415) a year earlier and ($244,142) in Q2 2026. Interest expense was $(74,412) and a $(146,754) loss on extinguishment of convertible debt was recorded, leaving a net loss of ($188,986) for the quarter, against ($450,348) in Q3 2025.

The balance sheet changed materially. Convertible notes payable, net, fell to $592,475 from $2,912,376 at December 31, 2025, and the company says $2.5 million of notes were converted in the quarter. Shareholders' equity rose to $4,012,524 from $588,504. Accounts receivable and accounts payable both increased, and cash was $195,162. The filing does not provide operating or free cash flow, so cash generation cannot be read from it.

The main point of attention is the reliability of the below-operating-line figures. The release says the accounting for the note conversion is still under review and that net loss, net loss per share and the related liability and equity balances are excluded, yet the printed statements show a net loss and a balance sheet equity figure. The company also expects equity at September 30, 2026 to fall between $3 million and $4 million, while the printed figure is $4,012,524. The release provides no numeric revenue, margin or expense guidance for Q4 2026; it refers to a backlog of approximately $2.8 million and a pipeline of approximately $35 million, with approximately 25% in advanced stages.

Management, verbatim

The third quarter represented an important inflection point for TOMI. Revenue increased 24% year-over-year and 11% sequentially, and we returned to positive operating income for the first time since the third quarter of 2024. This progress reflects stronger commercial execution, improved equipment sales and disciplined management of our operating cost base.

Dr. Halden Shane, CEO

The conversion of $2.5 million of convertible notes significantly reduced our debt obligations and expected annual cash interest commitment. Combined with an expanding backlog and commercial pipeline, we believe these improvements provide a stronger foundation as we work toward sustained profitability.

Dr. Halden Shane, CEO

Not in the filing

stated, not guessed
  • Net loss, net loss per share and the related liability and stockholders' equity balances are described in the release as not included pending the convertible notes accounting review, although the statement of operations prints net loss and the balance sheet prints equity; the final 10-Q may differ.
  • Prior-year and prior-quarter comparisons for the balance sheet are not printed on a like-for-like basis; balance sheet comparisons are against December 31, 2025, not a prior-year or prior-quarter period, and are therefore reported in balance_sheet_cash_flow only.
  • Year-over-year percentage changes for cost of sales, gross margin in basis points, and most operating expense lines are not printed and are left null.
  • Gross margin change for nine months 2026 is not printed.
  • Quarter-over-quarter changes for gross profit, cost of sales, and most line items are not printed.
  • Operating cash flow, investing cash flow, financing cash flow and free cash flow are not provided.
  • Forward guidance for revenue, gross margin, operating expenses and tax rate for Q4 2026 or full-year 2026 is not provided; only the shareholders' equity range is given.
  • Consensus estimates and the share price reaction are not provided in the filing.
  • Product and service revenue figures are printed as approximations in the highlights and text; exact statement-level product and service revenue lines are not in the financial statements.
  • Previous period outlook was not provided, so no guidance comparison is made.

Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. Guided figures in the outlook comparison come from the company’s previous release. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.

Questions about TOMZ earnings dates

When is TOMI Environmental Solutions's next earnings date?
AlphAI has no date for TOMZ yet. We do not publish estimates, so this page shows a date the day we have one.
Why is there sometimes no date?
AlphAI leaves out estimates. Many sites fill the gap by adding about 91 days to the last report, but that arithmetic is a guess, and a wrong date costs a reader more than a missing one, so we show nothing until a date is set, and a company can still move it. Every quarter already on this page is read straight from the SEC filing: an 8-K item 2.02 for US filers, a 6-K earnings release for foreign private issuers.